ASX - By Stock
|
ATH |
Re:
World congress of Antibiotic resistance this week
|
|
porhon
|
4 |
1.3K |
0 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
World congress of Antibiotic resistance this week
|
|
porhon
|
4 |
1.3K |
0 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
World congress of Antibiotic resistance this week
|
|
porhon
|
4 |
1.3K |
0 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Meeting with US FDA provides development path for ATH434
|
|
porhon
|
13 |
7.9K |
0 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
13
|
7.9K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
AMR Action Fund Opens European Office
|
|
porhon
|
8 |
2.3K |
1 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
8
|
2.3K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
NEW PAPER about ATH434 and endothelial cells !!!!
|
|
porhon
|
19 |
6.2K |
0 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
19
|
6.2K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Presentation today
|
|
porhon
|
19 |
8.1K |
0 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
19
|
8.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Presentation today
|
|
porhon
|
19 |
8.1K |
0 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
19
|
8.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Iron chelator protects endothelial cells in diabetes
|
|
porhon
|
3 |
2.0K |
1 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
3
|
2.0K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Impaired mitophagy , mechanism causing atrial fibrillation
|
|
porhon
|
3 |
1.4K |
0 |
31/01/21 |
31/01/21 |
ASX - By Stock
|
3
|
1.4K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
News: ATH Alterity Therapeutics Says David Stamler Appointed CEO
|
|
porhon
|
8 |
2.9K |
3 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
8
|
2.9K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
News: ATH Alterity Therapeutics Says David Stamler Appointed CEO
|
|
porhon
|
8 |
2.9K |
1 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
8
|
2.9K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Kempler's statement was strong
|
|
porhon
|
7 |
3.2K |
0 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
7
|
3.2K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Sirtuin 3 in AD
|
|
porhon
|
4 |
2.3K |
0 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
4
|
2.3K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Iron overload, even in children, related to metabolic disorders
|
|
porhon
|
3 |
1.1K |
0 |
19/07/20 |
19/07/20 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Iron overload in COVID-19
|
|
porhon
|
43 |
14K |
0 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
43
|
14K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Iron overload in COVID-19
|
|
porhon
|
43 |
14K |
0 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
43
|
14K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Iron overload in COVID-19
|
|
porhon
|
43 |
14K |
3 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
43
|
14K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
3.49 M is not much for ph2, how to get more
|
|
porhon
|
8 |
1.7K |
3 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
8
|
1.7K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Another abstract in AAN virtual meeting
|
|
porhon
|
14 |
3.5K |
2 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
14
|
3.5K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
New iron chelators enhancing NAD+ NADPH ratio
|
|
porhon
|
4 |
2.7K |
1 |
09/05/20 |
09/05/20 |
ASX - By Stock
|
4
|
2.7K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Remdesivir, no benefit for COVID- patients
|
|
porhon
|
26 |
5.6K |
3 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
26
|
5.6K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
porhon
|
12 |
3.0K |
1 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
12
|
3.0K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Remdesivir, no benefit for COVID- patients
|
|
porhon
|
26 |
5.6K |
0 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
26
|
5.6K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Remdesivir, no benefit for COVID- patients
|
|
porhon
|
26 |
5.6K |
4 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
26
|
5.6K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Remdesivir, no benefit for COVID- patients
|
|
porhon
|
26 |
5.6K |
3 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
26
|
5.6K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
corona- and arterivirus replication can be inhibited by increased Zn2+ levels
|
|
porhon
|
13 |
3.8K |
1 |
29/03/20 |
29/03/20 |
ASX - By Stock
|
13
|
3.8K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
corona- and arterivirus replication can be inhibited by increased Zn2+ levels
|
|
porhon
|
13 |
3.8K |
0 |
28/03/20 |
28/03/20 |
ASX - By Stock
|
13
|
3.8K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
UP 164% in NY
|
|
porhon
|
12 |
3.6K |
1 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
12
|
3.6K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Nasdaq Compliance
|
|
porhon
|
48 |
10K |
0 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
48
|
10K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
7009 shorted shares
|
|
porhon
|
9 |
3.1K |
2 |
12/03/20 |
12/03/20 |
ASX - By Stock
|
9
|
3.1K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Somebody invested $35.14
|
|
porhon
|
3 |
2.5K |
1 |
24/02/20 |
24/02/20 |
ASX - By Stock
|
3
|
2.5K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Somebody invested $35.14
|
|
porhon
|
3 |
2.5K |
0 |
24/02/20 |
24/02/20 |
ASX - By Stock
|
3
|
2.5K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
SIRT3 in hypertension, vascular dysfunction
|
|
porhon
|
3 |
1.8K |
0 |
22/02/20 |
22/02/20 |
ASX - By Stock
|
3
|
1.8K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
New All time Low
|
|
porhon
|
6 |
5.4K |
3 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
6
|
5.4K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
New All time Low
|
|
porhon
|
6 |
5.4K |
2 |
11/02/20 |
11/02/20 |
ASX - By Stock
|
6
|
5.4K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
NAD+ - mitophagy axsis in longevity
|
|
porhon
|
8 |
2.6K |
0 |
10/01/20 |
10/01/20 |
ASX - By Stock
|
8
|
2.6K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
NAD+ - mitophagy axsis in longevity
|
|
porhon
|
8 |
2.6K |
1 |
09/01/20 |
09/01/20 |
ASX - By Stock
|
8
|
2.6K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
NAD+ - mitophagy axsis in longevity
|
|
porhon
|
8 |
2.6K |
0 |
06/01/20 |
06/01/20 |
ASX - By Stock
|
8
|
2.6K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
NAD+ - mitophagy axsis in longevity
|
|
porhon
|
8 |
2.6K |
2 |
06/01/20 |
06/01/20 |
ASX - By Stock
|
8
|
2.6K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Risks associated with oral deferiprone
|
|
porhon
|
6 |
3.2K |
1 |
21/10/19 |
21/10/19 |
ASX - By Stock
|
6
|
3.2K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ketosis helps
|
|
porhon
|
1 |
518 |
1 |
10/07/19 |
10/07/19 |
ASX - By Stock
|
1
|
518
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Therapeutics presents to Finance News Network
|
|
porhon
|
8 |
3.2K |
0 |
09/06/19 |
09/06/19 |
ASX - By Stock
|
8
|
3.2K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Therapeutics presents to Finance News Network
|
|
porhon
|
8 |
3.2K |
0 |
08/06/19 |
08/06/19 |
ASX - By Stock
|
8
|
3.2K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Therapeutics presents to Finance News Network
|
|
porhon
|
8 |
3.2K |
1 |
07/06/19 |
07/06/19 |
ASX - By Stock
|
8
|
3.2K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Prana's new collaborators
|
|
porhon
|
1 |
727 |
3 |
07/04/19 |
07/04/19 |
ASX - By Stock
|
1
|
727
|
3
|
|
ASX - By Stock
|
ATH |
Re:
All 7 resolutions passed!
|
|
porhon
|
6 |
2.4K |
1 |
05/04/19 |
05/04/19 |
ASX - By Stock
|
6
|
2.4K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Okay AGM coming fast - any predictions
|
|
porhon
|
7 |
2.0K |
0 |
02/04/19 |
02/04/19 |
ASX - By Stock
|
7
|
2.0K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Who here has tried to contact prana.. Has anyone received a response?
|
|
porhon
|
11 |
5.2K |
6 |
05/03/19 |
05/03/19 |
ASX - By Stock
|
11
|
5.2K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
PBT2 from the Doherty Institute news site.
|
|
porhon
|
41 |
17K |
1 |
23/02/19 |
23/02/19 |
ASX - By Stock
|
41
|
17K
|
1
|
|